Paul F. Lambert

19.7k citations

300 papers · 15.0k indexed · 2 hit papers · h-index 67

Epidemiology top 0.1%
Molecular Biology top 0.5%
Oncology top 0.2%
Immunology top 0.5%
Genetics top 0.5%

Co-authors: Saewha Jeon Henry C. Pitot Denis Lee Peter M. Howley B. Lynn Allen‐Hoffmann Tiffany Brake Megan E. Spurgeon Elsa R. Flores
Topics: Cervical Cancer and HPV Research (136 papers)Cancer-related Molecular Pathways (59 papers)Virus-based gene therapy research (48 papers)
Cited by: Otorhinolaryngology Epidemiology Oncology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Australia Mexico

In The Last Decade

Paul F. Lambert

293 papers receiving 14.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis

2015 427 citations Paul F. Lambert et al. profile →
Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer

2013 293 citations Randall J. Kimple, Molly A. Smith et al. Cancer Research profile →

Peers

Countries citing papers authored by Paul F. Lambert

Since Specialization

Citations

This map shows the geographic impact of Paul F. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul F. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul F. Lambert more than expected).

Fields of papers citing papers by Paul F. Lambert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul F. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul F. Lambert. The network helps show where Paul F. Lambert may publish in the future.

Co-authorship network of co-authors of Paul F. Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Paul F. Lambert. A scholar is included among the top collaborators of Paul F. Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul F. Lambert. Paul F. Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AIB1 is a novel target of the high‐risk HPV E6 protein and a biomarker of cervical cancer progression 2022 ·Journal of Medical Virology ·(unknown),Aleksandra Dakic,Megan E. Spurgeon,(unknown),Bhaskar Kallakury,Bo Zhao,Junran Zhang,Jian Zhu,Qin Ma,Ying Xu,Paul F. Lambert,Richard Schlegel,Anna T. Riegel,Xuefeng Liu	7
2	Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade 2022 ·Clinical Cancer Research ·Wei Wang,(unknown),(unknown),Denis Lee,(unknown),(unknown),Mitchell Hayes,Justine Y. Bruce,Randall J. Kimple,Rong Hu,Paul M. Harari,Jin Xu,(unknown),Paul M. Sondel,Megan B. Fitzpatrick,Huy Q. Dinh,Paul F. Lambert	22
3	Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes 2018 ·Clinical Cancer Research ·(unknown),Susan Payne,Andrea Bilger,Kristina A. Matkowskyj,Evie H. Carchman,Dominique S. Meyer,Mohamed Bentires‐Alj,Dustin A. Deming,Paul F. Lambert	24
4	Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis 2018 ·Clinical Cancer Research ·(unknown),Darya Buehler,Paul F. Lambert	42
5	Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells 2018 ·Clinical Cancer Research ·Xueheng Zhao,(unknown),(unknown),Melinda Butsch Kovacic,Wujuan Zhang,Lindsey E. Romick‐Rosendale,Paul F. Lambert,Kenneth D.R. Setchell,Susanne I. Wells	19
6	The HPV16 E7 Oncoprotein Disrupts Dendritic Cell Function and Induces the Systemic Expansion of CD11b⁺Gr1⁺Cells in a Transgenic Mouse Model 2016 ·BioMed Research International ·(unknown),Nicolás Serafín‐Higuera,Mario Adán Moreno‐Eutímio,(unknown),(unknown),(unknown),Rodolfo Ocadiz‐Delgado,Paul F. Lambert,Patricio Gariglio	3
7	Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling 2015 ·Proceedings of the National Academy of Sciences ·Johan A. den Boon,Dohun Pyeon,Sophia Wang,Mark Horswill,Mark Schiffman,Mark E. Sherman,Rosemary E. Zuna,Zhishi Wang,Stephen M. Hewitt,(unknown),(unknown),Lisa Chung,Qiuling He,Paul F. Lambert,Joan L. Walker,Michael A. Newton,Nicolas Wentzensen,Paul Ahlquist	222
8	Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling 2015 ·Clinical Cancer Research ·Lindsey E. Romick‐Rosendale,Elizabeth E. Hoskins,Lisa M. Privette Vinnedge,(unknown),(unknown),S. Steven Potter,Kakajan Komurov,Samantha A. Brugmann,Paul F. Lambert,Randall J. Kimple,Elizabeth L. Virts,Helmut Hanenberg,Maura L. Gillison,Susanne I. Wells	25
9	Tumorigenic Activity of Merkel Cell Polyomavirus T Antigens Expressed in the Stratified Epithelium of Mice 2015 ·Cancer Research ·Megan E. Spurgeon,Jingwei Cheng,Roderick T. Bronson,Paul F. Lambert,James A. DeCaprio	59
10	Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancerbreakdown → 2013 ·Cancer Research ·Randall J. Kimple,Molly A. Smith,Grace C. Blitzer,Alexandra D. Torres,Joshua A. Martin,Robert Yang,Chimera R. Peet,Laurel D. Lorenz,Kwangok P. Nickel,Aloysius J. Klingelhutz,Paul F. Lambert,Paul M. Harari	293
11	Inactivating All Three Rb Family Pocket Proteins Is Insufficient to Initiate Cervical Cancer 2012 ·Cancer Research ·(unknown),Julien Sage,Paul F. Lambert	30
12	Pocket Proteins Suppress Head and Neck Cancer 2012 ·Cancer Research ·(unknown),Henry C. Pitot,Paul F. Lambert	19
13	The E6 Oncoprotein from HPV16 Enhances the Canonical Wnt/β-Catenin Pathway in Skin Epidermis In Vivo 2011 ·Molecular Cancer Research ·(unknown),Gülay Bulut,Xuefeng Liu,(unknown),Richard Schlegel,Catalina Flores-Maldonado,R. Contreras,Sang‐Hyuk Chung,Paul F. Lambert,Aykut Üren,Patricio Gariglio	42
14	CARM1 Is an Important Determinant of ERα-Dependent Breast Cancer Cell Differentiation and Proliferation in Breast Cancer Cells 2011 ·Cancer Research ·(unknown),Jiacai Wu,Georgios Skliris,Jun Li,(unknown),Yidan Wang,K White,Paul F. Lambert,Yuerong Zhu,Leigh C. Murphy,Wei Xu	77
15	Deficiencies in the Fanconi Anemia DNA Damage Response Pathway Increase Sensitivity to HPV-Associated Head and Neck Cancer 2010 ·Cancer Research ·Jung Wook Park,Henry C. Pitot,Katerina Strati,Nicole A. Spardy,Stefan Duensing,Markus Grompe,Paul F. Lambert	67
16	A Mouse Model for Human Anal Cancer 2010 ·Cancer Prevention Research ·(unknown),Henry C. Pitot,Amy Liem,Johannes Schweizer,(unknown),Paul F. Lambert	49
17	Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene 2009 ·Cancer Research ·(unknown),Linda Abrams,Adam B. Glick,Paul F. Lambert	74
18	p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers 2008 ·Cancer Research ·Anny Shai,Henry C. Pitot,Paul F. Lambert	45
19	Human Papillomavirus 16 E5 Oncogene Contributes to Two Stages of Skin Carcinogenesis 2007 ·Cancer Research ·John P. Maufort,Sybil M. Genther Williams,Henry C. Pitot,Paul F. Lambert	54
20	Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical Cancers 2007 ·Cancer Research ·Dohun Pyeon,Michael A. Newton,Paul F. Lambert,Johan A. den Boon,Srikumar Sengupta,Carmen J. Marsit,Craig D. Woodworth,Joseph P. Connor,Thomas H. Haugen,Elaine Smith,Karl T. Kelsey,Lubomír P. Turek,Paul Ahlquist	382

About Paul F. Lambert

Paul F. Lambert is a scholar working on Epidemiology, Otorhinolaryngology and Oncology, having authored 300 papers that have together received 15.0k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (136 papers), Cancer-related Molecular Pathways (59 papers) and Virus-based gene therapy research (48 papers). The work is most often cited by research in Otorhinolaryngology (1.1k citations), Epidemiology (7.1k citations) and Oncology (4.9k citations). Paul F. Lambert has collaborated with scholars based in United States, Australia and Mexico. Frequent co-authors include Saewha Jeon, Henry C. Pitot, Denis Lee, Peter M. Howley, B. Lynn Allen‐Hoffmann, Tiffany Brake, Megan E. Spurgeon, Elsa R. Flores, Dohun Pyeon and Amy Liem. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact